Neuroinvasion by pathogens: A key role of the complement system

Molecular Immunology

Volumn 38, Issue 9, 2002, Pages 669-679

  Speth, Cornelia ^a   Dierich, Manfred P ^a   Gasque, Philippe ^b  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Bacteria; Complement; Glial cells; Innate immunology; Neurodegeneration; Neuroinvasion; Neurons; Prion; Virus

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT RECEPTOR; MEMBRANE COFACTOR PROTEIN; RECEPTOR SUBTYPE;

ARTICLE; BACTERIAL INFECTION; BIOSYNTHESIS; BRAIN; BRAIN INFECTION; CENTRAL NERVOUS SYSTEM; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; EPSTEIN BARR VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFLAMMATION; LYSIS; MEASLES VIRUS; MYCOSIS; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRION DISEASE; PRIORITY JOURNAL; TISSUE INJURY; VACCINIA VIRUS;

ANIMALS; BACTERIAL INFECTIONS; BRAIN; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNITY, NATURAL; MYCOSES; PRION DISEASES;

EQUIDAE; FUNGI;

EID: 0036174536     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(01)00104-3     Document Type: Article

References (87)

1. Complement receptors
2. Relative efficiency of microglia, astrocytes, dendritic cells and B cells in naïve CD4+ T cell priming and Th1/Th2 restimulation
3. Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules
4. Patterns of resistance to Candida albicans in inbred mouse strains
5. Epstein-Barr virus-associated acute autonomic neuropathy
6. Pathogenicity of Saccharomyces cerevisiae in C factor five-deficient mice
7. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells
8. Expression of complement inhibitor protein CD59 in human neuronal and glial cell lines treated with HIV-1 gp41 peptides
9. Neurologic complications of infectious mononucleosis
10. Role of astrocytes in antigen presentation and naive T cell activation
11. Gene expression in scrapie. Cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts
12. Terminal complement complexes concomitantly stimulate proliferation and rescue of Schwann cells from apoptosis
13. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis
14. Activation of the alternative C pathway by Newcastle disease virus. Effect of the virus on the C system in vivo and in vitro
15. Expression of C1q, a subcomponent of the rat C system, is dramatically enhanced in brains of rats with either Borna disease of experimental allergic encephalomyelitis
16. Characterization of complement anaphylatoxins and their biological responses
17. Nervous-tissue as an immune compartment - The dialect of the immune-response in the CNS
18. A neuronal C5a receptor and an associated apoptotic signal transduction pathway
19. Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells
20. Treatment of pneumococcic meningitis. A study of 10 cases treated with sulfanilamide alone or in various combinations with specific anti-pneumococcic serum and complement, including six recoveries
21. The role of complement in inflammation and phagocytosis
22. Acquisition of host cell-surface-derived molecules by HIV-1
23. Activation of astrocytes by anaphylatoxins of the C system
24. Mechanisms of hyperpolarization of plasma membrane of macrophages and astrocytes during activation
25. Identification and characterization of complement C3 receptors on human astrocytes
26. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: Analysis in multiple sclerosis and bacterial meningitis
27. Complement components of the innate immune system in health and disease in the CNS
28. Nonimmune activation of the classical complement pathway
29. Neuropathology of early HIV-1 infection
30. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins
31. Inflammatory signals induce neurotrophin expression in human microglial cells
32. C factor C5a and epidermal growth factor trigger the activation of outward potassium currents in cultured murine microglia
33. Quantitation of human immunodeficiency virus in brain of demented and nondemented patients with acquired immunodeficiency syndrome
34. Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system
35. Arachidonic acid as a neurotoxic and neurotrophic substance
36. Complement facilitates early prion pathogenesis
37. Stable expression of HIV-1 Nef induces changes in growth properties and activation state of human astrocytes
38. Primary cultures of murine astrocytes produce C-3 and factor-B, 2 components of the alternative pathway of complement activation
39. Temporary depletion of complement C3 or genetic deficiency of C1q significantly delays onset of scrapie
40. Complement activation by HIV-1-infected cells: The role of transmembrane glycoprotein gp41
41. Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46)
42. Clinical isolates of measles virus use CD46 as a cellular receptor
43. Patterns of neurodegeneration in HIV encephalitis
44. Epstein-Barr virus infection of human astrocyte cell lines
45. Epstein-Barr virus regulates activation and processing of the third component of C
46. Characterization of a complement receptor 2 (CR2 CD21) ligand binding site for C. An initial model of ligand interaction with two linked short consensus repeat modules
47. Mechanisms of C5a and C3a C fragment-induced [Ca2+]i signaling in mouse microglia
48. Complement deficiency and disease
49. Expression of complement in the brain: Role in health and disease
50. Extrahepatic complement biosynthesis: Where, when and why?
51. Regulation in the complement system
52. Measles virus haemagglutinin induces down-regulation of gp57/67, a molecule involved in virus binding
53. The AIDS dementia complex: I. Clinical features
54. Considerations in choice of a clinical endpoint for AIDS clinical trials
55. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex and C
56. C 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton
57. Absence of measles virus receptor (CD46) in lesions of subacute sclerosing panencephalitis brains
58. Expression of C5a receptor in mouse brain: Role in signal transduction and neurodegeneration
59. C-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity
60. Understanding the AIDS dementia complex (ADC). The challenge of HIV and its effects on the central nervous system
61. AIDS dementia complex: A complex, slow virus ≪model≫ of acquired genetic neurodegenerative disease
62. HIV-1 associated dementia: Clinical features and pathogenesis
63. Epstein-Barr virus
64. Induction of C3 expression in astrocytes is regulated by cytokines and newcastle disease virus
65. Sublytic C attack induces cell cycle in oligodendrocytes
66. Terminal C complexes induce cell cycle entry in oligodendrocytes through mitogen activated protein kinase pathway
67. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: Specific increase in interleukin-6 mRNA expression
68. Measles virus-induced down-regulation of CD46 is associated with enhanced sensitivity to complement-mediated lysis of infected cells
69. Psychopharmacological activity of anaphylatoxin C3a in rat hypothalamus
70. Normal rat serum cyto-toxicity against syngeneic oligodendrocytes - Complement activation and attack in the absence of anti-myelin antibodies
71. Intracellular signaling mediating HIV-1 gp120 neurotoxicity
72. Release of leukotriene B4 from sublethally injured oligodendrocytes by terminal C complexes
73. Arachidonic acid mobilization and phosphoinositide turnover by the terminal C complex, C5b-9, in rat oligodendrocyte x C6 glioma cell hybrids
74. Enhanced degradation of messenger RNA encoding myelin proteins by terminal C complexes in oligodendrocytes
75. Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation
76. The complement system: Pathophysiology and clinical relevance
77. HIV-1 induces expression of C factors in human astrocytes
78. Bacterial meningitis: Complement gene expression in the central nervous system
79. Human complement proteins C3b, C4b, factor H and properdin react with specific sites in gp120 and gp41, the envelope proteins of HIV-1
80. Epstein-Barr virus binding to CD21 activates the initial viral promoter via NFkB induction
81. Complement activation by recombinant HIV-1 glycoprotein gp120
82. SLAM (CDw150) is a cellular receptor for measles virus
83. Mannose-binding lectin: The pluripotent molecule of the innate immune system
84. Membrane cofactor protein (MCP CD46): Isoform-specific tyrosine phosphorylation
85. The neuropharmacology of immune complex activity in the rat hypothalamus
86. Anaphylatoxin C5a modulation of an alpha-adrenergic receptor system in the rat hypothalamus
87. Chemotaxis by a CNS macrophage, the microglia